8.600
+0,00%
2026-10-19
Fundamental Analysis
33 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -96.8% | -11.2% | 1 / 3 | -94.4% | +29.49 pp | -0.17 pp | +1.5% | 0.79 | 45.74 | 6,9 | −94,4% | 0,0 | −96,8% | 45.74 | 27.11 | +68,7% |
| Pts | 0 | 0 | 4 | 0 | 12 | 4 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 8.600 (close price on 2026-10-19)EPS (TTM): 188,0
Financial charts
1.Revenue & growth
VND bn6,90Q2/26
1.Revenue & growth
VND bn6,90Q2/26
2.Profit & growth
VND bn0,10Q2/26
3.Profit mix (Penman)
VND bn3,85Q2/26
4.Margins & cost structure
%2.3%Q2/26
5.Returns & cash cycle
% · days-0.3%Q2/26
6.Earnings quality & cash
VND bn60,1Q2/26
7.Asset structure
VND bn308Q2/26
8.Funding & debt health
VND bn · times308Q2/26
9.Revenue backlog
VND bn2,71Q2/26
10.Valuation
times · %75,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %8Q2/26
Adjusted EPS growth, latest quarter
-80.6%
Average adjusted EPS growth, 3 quarters
-56.2%
averaged over 2 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26